Phil Rodgers, Pharm.D.

Clinical Associate Professor

Philip Rodgers, Pharm.D., is a clinical associate professor at the UNC Eshelman School of Pharmacy. He coordinates several courses in the School, including the Patient Care Experience course (PHCY 617) and the Ambulatory Care Elective (PACE 803). He also serves as a faculty advisor for the Carolina Association of Pharmacy Students (CAPS). Rodgers received his Bachelor of Science in pharmacy and his Doctor of Pharmacy from the University of North Carolina at Chapel Hill. After earning his Pharm.D., he completed a pharmacy residency in ambulatory care at the Medical College of Virginia Hospitals in Richmond, Virginia. His areas of scholarship and teaching are primary care pharmacy practice, chronic disease management and innovative pharmacy education programs. Rodgers has been named a fellow of the American College of Clinical Pharmacy.

Rodgers previously served as assistant dean of pharmacy practice partnerships at the School. Prior to joining the School, he was a clinical pharmacist and faculty in ambulatory care at Duke University Hospital, where he was designated a clinical pharmacist practitioner as per the state of North Carolina in the areas of diabetes, hypertension, and anticoagulation. Rodgers also served as director for the ASHP-accredited PGY2 Ambulatory Care Pharmacy Residency program at Duke Hospital for eleven years and as the director of pharmacy education for the Duke Area Health Education Center for nine years. He previously served as the American Pharmacists Association representative to the National Diabetes Education Program.

Publications

  • Rodgers PT*, Tingen JM.  Chapter 21: Teaching Responsibilities.  In: Crouch MA, editor. Securing and Excelling in a Pharmacy Residency. 1st ed. Sudbury, Massachusetts: Jones and Bartlett Learning; 2011.
  • Gavin JR*, Peragallo-Dittko V*, Rodgers PT*.  A new look at established therapies:  practical tools for optimizing insulin use.  Diabetes Educ 2010;36(suppl):26s-36s.
  • Weber ZA, Rodgers PT*.  The clinical significance of the interaction between proton pump inhibitors and clopidogrel.  J Pharm Technol 2010;26:22-6.
  • Carter BL*, Clarke W, Ardery G et al. A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Circulation: Cardiovasc Qual Outcomes 2010;3:418-423. [acknowledged site co-investigator]
  • Haase KK*, Smythe MA, Orlando PL, Resman-Targoff BH, Smith LS.  Contributors: Herner SJ, Melnyk SD, Paolini NM, Porter KB, Rodgers PT, Spunt AL. Quality experiential education.  Pharmacotherapy 2008;28:1547.
  • Masica AL, Touchette DR*, Dolor RJ, Schumock GT, Kliethermes MA, Rodgers PT, Craft JL, Choi YK, Lux LJ, Smith SR. Evaluation of a Medication Therapy Management Program in Medicare Beneficiaries at High Risk of Adverse Drug Events: Study Methods.  In Advances in Patient Safety: New Directions and Alternative Approaches. Vol.4. Technology and Medication Safety. AHRQ Publication No 08-0034-4. Rockville MD: Agency for Healthcare Research and Quality; August 2008.
  • Rodgers PT*.  Question and Answers: Sickle cell anemia & HbA1c level.  Diabetes Self-Management Nov/Dec 2007:71-2.
  • Murphy CE, Rodgers PT*. Effects of thiazolidinediones on bone loss and fracture.  Ann Pharmacother 2007;41:2014-8.

Presentations

Select Poster Presentations

  • Cox WC*, Rodgers PT.  Using Team-Based Learning in an Ambulatory Care Course.  AACP Annual Meeting and Seminars Poster; July 20-21, 2009.
  • Joy SV*, Rodgers PT.  An Analysis of the Work Effort Required for Electronic Prescriptions Following the Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes Management of Hyperglycemia in Patients with Type 2 Diabetes.  ADA Scientific Sessions, Poster 1193-P; June 7, 2009.
  • Bowlby L*, Rodgers P*, Colquhoun J, Crowley M, McNeill D, Burgess L.  Improving patient safety/care via eBrowser Protocol in the C-II prescription process.   APDIM Conference; April 28, 2009 (blue ribbon winner).

Select Invited National and International Presentations

  • “Pharmacists as part of the diabetes care team”.  American Academy of Optometry, November 12, 2009.
  • “Diabetes update 2009.”  APHA Annual Meeting and Exposition, April 4, 2009
  • “Managing Patients with Multiple Metabolic Abnormalities”  2007 APhA Annual Meeting and Exposition, March 18, 2007.
  • “Cardiometabolic Risk:  The Heart of the Matter.” Keynote Presentation, 2007 Iowa Pharmacy Association Educational Expo, January 26, 2007.
  • “Innovations in Diabetes Management.”  Breakout session, 2007 Iowa Pharmacy Association Educational Expo, January 26, 2007.

Select Invited State and Local Presentations

  • “Hot topics in diabetes management.”  Durham-Orange Pharmaceutical Association, October 19, 2011
  • “Hot topics in diabetes management.”  Kappa Psi Providence III Convocation, September 24, 2011
  • “Hot topics in diabetes management.”  Triangle College of Clinical Pharmacy, August 31, 2011.
  • “Precepting pharmacy students: The reality show.” Pharmacy Department Noon Conference, May 23, 2011.
  • “The rise and fall of rosiglitazone:  Lessons learned.”  NCAP Acute Care Meeting, March 25, 2011.
  • “What’s new for diabetes in 2010?”  MAST Symposium, November 10, 2010.
  • “Updates in diabetes for 2010:  Applications in Practice.”  Pharmacy Practice Seminar, August 28, 2010.
  • “Diabetes pharmacotherapy in 2009.”  Southern Regional AHEC CE, August 20, 2009.
  • “What’s new in managing diabetic peripheral neuropathy?”  Southeastern AHEC CE Program, December 4, 2008.
  • “Managing the pain in…my feet.”  Pharmacy Practice Seminar, October 18, 2008.
  • “Safe and Effective Use of Insulin” Duke Hospital Clinical Pharmacology Series, May 15, 2008.
  • “Hurdle 3: What’s new in diabetes drug therapy?”  Metrolina Association of Diabetes Educators 2008 Annual Diabetes Conference, April 17, 2008.
  • “Diabetes mellitus:  A 2008 pharmacotherapy update on glucose management.”  PPD CE program, Feb 26, 2008.
  • “A critical analysis of drug safety:  The story of rosiglitazone and other drugs”.  NCAP Acute Care Forum, Feb 5, 2008.
  • “Update in Diabetes Pharmacotherapy” Southern Regional AHEC CE, Nov 15, 2007.
  • “Significant papers in Pharmacotherapy”.  TCCP CE, Nov 6, 2007
  • “Managing cardiovascular risk in patients with the metabolic syndrome”  Pharmacy Practice Seminar, Sept 8, 2007.
  • “Safe and Effective Use of Insulin” Duke Hospital Clinical Pharmacology Series, May 17, 2007.
  • “Metabolic Syndrome:  A True Heartbreaker” NCAP Acute Care Practice Forum, April 26, 2007.
  • “Update in Diabetes Pharmacotherapy” Southern Regional AHEC CE, March 15, 2007.
  • Bachelor of Science in Pharmacy, University of North Carolina at Chapel Hill, 1992
  • Doctor of Pharmacy, University of North Carolina at Chapel Hill, 1995
  • Residency in Ambulatory Care/Primary Care, Medical College of Virginia Hospitals, 1996
  • Board Certified Pharmacotherapy Specialist